 Lymph Node Excision
"Lymph Node Excision" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
| Descriptor ID |
D008197
|
| MeSH Number(s) |
E04.446
|
| Concept/Terms |
Lymph Node Excision- Lymph Node Excision
- Excision, Lymph Node
- Excisions, Lymph Node
- Lymph Node Excisions
- Lymphadenectomy
- Lymphadenectomies
Lymph Node Dissection- Lymph Node Dissection
- Dissection, Lymph Node
- Dissections, Lymph Node
- Lymph Node Dissections
- Node Dissection, Lymph
- Node Dissections, Lymph
|
Below are MeSH descriptors whose meaning is more general than "Lymph Node Excision".
Below are MeSH descriptors whose meaning is more specific than "Lymph Node Excision".
This graph shows the total number of publications written about "Lymph Node Excision" by people in this website by year, and whether "Lymph Node Excision" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 2 | 2 | | 1987 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 | | 1993 | 2 | 2 | 4 | | 1994 | 2 | 0 | 2 | | 1996 | 2 | 1 | 3 | | 1997 | 0 | 1 | 1 | | 1999 | 1 | 3 | 4 | | 2000 | 0 | 2 | 2 | | 2001 | 1 | 3 | 4 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 5 | 6 | | 2004 | 3 | 0 | 3 | | 2005 | 2 | 3 | 5 | | 2006 | 2 | 0 | 2 | | 2007 | 5 | 2 | 7 | | 2008 | 4 | 1 | 5 | | 2009 | 7 | 2 | 9 | | 2010 | 5 | 1 | 6 | | 2012 | 5 | 4 | 9 | | 2013 | 8 | 6 | 14 | | 2014 | 2 | 4 | 6 | | 2015 | 5 | 4 | 9 | | 2016 | 6 | 4 | 10 | | 2017 | 5 | 5 | 10 | | 2018 | 4 | 2 | 6 | | 2019 | 6 | 7 | 13 | | 2020 | 2 | 4 | 6 | | 2021 | 0 | 3 | 3 | | 2022 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymph Node Excision" by people in Profiles.
-
Ascierto PA, Warner AB, Blank C, Caracò C, Demaria S, Gershenwald JE, Khushalani NI, Long GV, Luke JJ, Mehnert JM, Robert C, Rutkowski P, Tawbi HA, Osman I, Puzanov I. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. J Transl Med. 2022 05 10; 20(1):200.
-
Fankhauser CD, Afferi L, Stroup SP, Rocco NR, Olson K, Bagrodia A, Baky F, Cazzaniga W, Mayer E, Nicol D, Islamoglu E, de Vergie S, Saoud R, Eggener SE, Nazzani S, Nicolai N, Hugar L, Sexton WJ, Matei DV, De Cobelli O, Cheaib J, Pierorazio PM, Porter J, Hermanns T, Hamilton RJ, Hiester A, Albers P, Clarke N, Mattei A. Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility. World J Urol. 2022 Jun; 40(6):1505-1512.
-
Ozaki K, Kawai K, Nozawa H, Sasaki K, Murono K, Emoto S, Abe H, Ushiku T, Ishihara S. Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2022 Feb; 37(2):467-473.
-
Bredbeck BC, Baskin AS, Wang T, Sinco BR, Berlin NL, Shubeck SP, Mott NM, Greenup RA, Nathan H, Hughes TM, Dossett LA. Incremental Spending Associated with Low-Value Treatments in Older Women with Breast Cancer. Ann Surg Oncol. 2022 Feb; 29(2):1051-1059.
-
Chatani PD, Aversa JG, McDonald JD, Khan TM, Keutgen XM, Nilubol N. Preoperative serum chromogranin-a is predictive of survival in locoregional jejuno-ileal small bowel neuroendocrine tumors. Surgery. 2021 07; 170(1):106-113.
-
Kantor O, Chang C, Yao K, Boughey J, Roland C, Francescatti AB, Blair S, Dickson Witmer D, Hunt KK, Nelson H, Weiss A, Oseni T. Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Sep; 28(9):4995-5004.
-
Rooney MK, Korpics MC, Turchan WT, Callahan N, Koshy M, Spiotto MT. Patterns of Care and Survival Outcomes for Odontogenic Cancers. Laryngoscope. 2021 05; 131(5):E1496-E1502.
-
Kwan JYY, Famiyeh P, Su J, Xu W, Kwan BYM, Jones JM, Chang E, Yip KW, Liu FF. Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema. JAMA Netw Open. 2020 11 02; 3(11):e2024373.
-
Naughton MJ, Liu H, Seisler DK, Le-Rademacher J, Armer JM, Oliveri JM, Sloan JA, Hock K, Schwartz M, Unzeitig G, Melnik M, Yee LD, Fleming GF, Taylor JR, Loprinzi C, Paskett ED. Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients. Cancer. 2021 01 15; 127(2):300-309.
-
Paskett ED, Le-Rademacher J, Oliveri JM, Liu H, Seisler DK, Sloan JA, Armer JM, Naughton MJ, Hock K, Schwartz M, Unzeitig G, Melnik M, Yee LD, Fleming GF, Taylor JR, Loprinzi C. A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance). Cancer. 2021 01 15; 127(2):291-299.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|